Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockman6767on Apr 22, 2021 9:12am
49 Views
Post# 33043548

RE:RE:You can thank

RE:RE:You can thankDrybones, I already posted on this some days ago. The news has been out for many weeks now. I posted this several days ago:

"where have you been for the last 6-7 weeks. Yes it was filed in Quebec Superior Court in Laval on Frn 25, 2021 and was served on LMNL a few days later for approx $700 M US$.

LMNL has reported this in two official places. they filed a Form-20 required by the SEC in the US and can be found on EDGAR, and LMNL also reported the lawsuit in their 2020 annual report in a subsequent events section and can be found on SEDAR in Canada.

Finally, the JDM has reported on the lawsuit as well last Saturday.
<< Previous
Bullboard Posts
Next >>